FDA rejects epinephrine nasal spray and Taylor Swift vault search glitches: Morning Rundown

Drugmaker ARS Pharmaceuticals said it plans to appeal the Food and Drug Administration’s request for additional data after the agency’s rejection of the drug Neffy.